Following this appointment and Glintt's acceptance as a member of the EIT Health (European Institute of Innovation & Technology), CEO Nuno Vasco Lopes was elected Lisbon representative, as a member of the InnoStars EIT Health Supervisory Board.
This represents a major achievement for the Portuguese multinational, which has been a member of the EIT Health Consortium since last August. Prevention is the motto of this Consortium, which seeks to bring healthcare sector players together and facilitate access to European markets. The Consortium's goal is to create the necessary conditions to address European challenges and improve citizens' health and wellness.
As a member of these bodies, Glintt will be better able to follow trends and monitor the most recent innovations in health, prevention and wellness, as well as take advantage from opportunities to develop and test new solutions in European markets.
Have placed Glintt at the forefront of solution development for the healthcare sector, these appointments allow the company to participate in the development of new ideas, pilot projects and solutions, alongside key European institutions, companies, healthcare facilities and research centres.